GO:0006521 | regulation of cellular amino acid metabolic process | 3.90e-07 | 5.63e-03 | 7.435 | 3 | 17 | 50 |
GO:0000502 | proteasome complex | 6.14e-07 | 8.85e-03 | 7.221 | 3 | 17 | 58 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 8.28e-07 | 1.19e-02 | 7.079 | 3 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 8.68e-07 | 1.25e-02 | 7.057 | 3 | 22 | 65 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.09e-06 | 1.57e-02 | 6.950 | 3 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.18e-06 | 1.71e-02 | 6.909 | 3 | 20 | 72 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.29e-06 | 1.86e-02 | 6.870 | 3 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.34e-06 | 1.93e-02 | 6.850 | 3 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.57e-06 | 2.26e-02 | 6.775 | 3 | 23 | 79 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.49e-06 | 3.59e-02 | 6.556 | 3 | 21 | 92 |
GO:0000209 | protein polyubiquitination | 5.01e-06 | 7.23e-02 | 6.221 | 3 | 20 | 116 |
GO:0005838 | proteasome regulatory particle | 6.34e-06 | 9.14e-02 | 8.909 | 2 | 7 | 12 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.06e-05 | 1.54e-01 | 5.860 | 3 | 32 | 149 |
GO:0042981 | regulation of apoptotic process | 1.09e-05 | 1.57e-01 | 5.850 | 3 | 24 | 150 |
GO:0022624 | proteasome accessory complex | 1.30e-05 | 1.88e-01 | 8.407 | 2 | 8 | 17 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.61e-05 | 2.32e-01 | 5.661 | 3 | 20 | 171 |
GO:0016071 | mRNA metabolic process | 3.56e-05 | 5.14e-01 | 5.278 | 3 | 31 | 223 |
GO:0016070 | RNA metabolic process | 4.84e-05 | 6.98e-01 | 5.131 | 3 | 32 | 247 |
GO:0070062 | extracellular vesicular exosome | 1.27e-04 | 1.00e+00 | 2.587 | 5 | 104 | 2400 |
GO:0005654 | nucleoplasm | 1.48e-04 | 1.00e+00 | 3.415 | 4 | 76 | 1082 |
GO:0005829 | cytosol | 1.55e-04 | 1.00e+00 | 2.531 | 5 | 132 | 2496 |
GO:0000278 | mitotic cell cycle | 1.90e-04 | 1.00e+00 | 4.468 | 3 | 48 | 391 |
GO:0044281 | small molecule metabolic process | 2.31e-04 | 1.00e+00 | 3.252 | 4 | 58 | 1211 |
GO:0043066 | negative regulation of apoptotic process | 2.41e-04 | 1.00e+00 | 4.351 | 3 | 31 | 424 |
GO:0019521 | D-gluconate metabolic process | 3.47e-04 | 1.00e+00 | 11.494 | 1 | 1 | 1 |
GO:0016032 | viral process | 4.77e-04 | 1.00e+00 | 4.018 | 3 | 55 | 534 |
GO:0006915 | apoptotic process | 5.35e-04 | 1.00e+00 | 3.963 | 3 | 33 | 555 |
GO:0019322 | pentose biosynthetic process | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 2 | 2 |
GO:0010467 | gene expression | 9.26e-04 | 1.00e+00 | 3.693 | 3 | 59 | 669 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 2 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 1.04e-03 | 1.00e+00 | 9.909 | 1 | 1 | 3 |
GO:0043248 | proteasome assembly | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 5 |
GO:0030957 | Tat protein binding | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 3 | 6 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 4 | 8 |
GO:0070688 | MLL5-L complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 8 |
GO:0006098 | pentose-phosphate shunt | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 4 | 10 |
GO:0030234 | enzyme regulator activity | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 3 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 4 | 14 |
GO:0050998 | nitric-oxide synthase binding | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 3 | 16 |
GO:0005839 | proteasome core complex | 6.23e-03 | 1.00e+00 | 7.324 | 1 | 8 | 18 |
GO:0004298 | threonine-type endopeptidase activity | 6.57e-03 | 1.00e+00 | 7.246 | 1 | 8 | 19 |
GO:0048863 | stem cell differentiation | 6.57e-03 | 1.00e+00 | 7.246 | 1 | 1 | 19 |
GO:0030863 | cortical cytoskeleton | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 7.95e-03 | 1.00e+00 | 6.971 | 1 | 4 | 23 |
GO:0031492 | nucleosomal DNA binding | 9.33e-03 | 1.00e+00 | 6.739 | 1 | 4 | 27 |
GO:0050661 | NADP binding | 9.33e-03 | 1.00e+00 | 6.739 | 1 | 2 | 27 |
GO:0019894 | kinesin binding | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 28 |
GO:0001895 | retina homeostasis | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.28e-02 | 1.00e+00 | 6.285 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 1.31e-02 | 1.00e+00 | 6.246 | 1 | 2 | 38 |
GO:0016020 | membrane | 1.32e-02 | 1.00e+00 | 2.364 | 3 | 90 | 1681 |
GO:0021762 | substantia nigra development | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 2 | 44 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 54 |
GO:0000932 | cytoplasmic mRNA processing body | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 3 | 54 |
GO:0034329 | cell junction assembly | 2.34e-02 | 1.00e+00 | 5.407 | 1 | 1 | 68 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 6 | 74 |
GO:0005200 | structural constituent of cytoskeleton | 3.12e-02 | 1.00e+00 | 4.986 | 1 | 8 | 91 |
GO:0006928 | cellular component movement | 3.12e-02 | 1.00e+00 | 4.986 | 1 | 7 | 91 |
GO:0014069 | postsynaptic density | 3.59e-02 | 1.00e+00 | 4.780 | 1 | 3 | 105 |
GO:0005634 | nucleus | 3.73e-02 | 1.00e+00 | 1.340 | 4 | 136 | 4559 |
GO:0072562 | blood microparticle | 3.79e-02 | 1.00e+00 | 4.700 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 8 | 112 |
GO:0006325 | chromatin organization | 4.02e-02 | 1.00e+00 | 4.612 | 1 | 5 | 118 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 5 | 126 |
GO:0009615 | response to virus | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 4.39e-02 | 1.00e+00 | 4.483 | 1 | 9 | 129 |
GO:0006457 | protein folding | 4.86e-02 | 1.00e+00 | 4.334 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 4.93e-02 | 1.00e+00 | 4.314 | 1 | 7 | 145 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 5.59e-02 | 1.00e+00 | 4.128 | 1 | 7 | 165 |
GO:0030424 | axon | 5.62e-02 | 1.00e+00 | 4.119 | 1 | 4 | 166 |
GO:0005975 | carbohydrate metabolic process | 8.47e-02 | 1.00e+00 | 3.511 | 1 | 9 | 253 |
GO:0005856 | cytoskeleton | 9.69e-02 | 1.00e+00 | 3.309 | 1 | 12 | 291 |
GO:0043234 | protein complex | 9.82e-02 | 1.00e+00 | 3.290 | 1 | 18 | 295 |
GO:0019901 | protein kinase binding | 1.05e-01 | 1.00e+00 | 3.186 | 1 | 21 | 317 |
GO:0007411 | axon guidance | 1.06e-01 | 1.00e+00 | 3.177 | 1 | 13 | 319 |
GO:0005925 | focal adhesion | 1.21e-01 | 1.00e+00 | 2.978 | 1 | 19 | 366 |
GO:0055114 | oxidation-reduction process | 1.37e-01 | 1.00e+00 | 2.780 | 1 | 12 | 420 |
GO:0007596 | blood coagulation | 1.48e-01 | 1.00e+00 | 2.664 | 1 | 18 | 455 |
GO:0044267 | cellular protein metabolic process | 1.54e-01 | 1.00e+00 | 2.605 | 1 | 29 | 474 |
GO:0045087 | innate immune response | 1.90e-01 | 1.00e+00 | 2.275 | 1 | 24 | 596 |
GO:0005615 | extracellular space | 2.91e-01 | 1.00e+00 | 1.592 | 1 | 17 | 957 |
GO:0005515 | protein binding | 3.48e-01 | 1.00e+00 | 0.523 | 3 | 184 | 6024 |
GO:0005524 | ATP binding | 3.76e-01 | 1.00e+00 | 1.152 | 1 | 60 | 1298 |
GO:0005737 | cytoplasm | 3.91e-01 | 1.00e+00 | 0.615 | 2 | 110 | 3767 |
GO:0005730 | nucleolus | 4.53e-01 | 1.00e+00 | 0.814 | 1 | 69 | 1641 |